FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2074335074> ?p ?o ?g. }

• W2074335074 endingPage "506" @default.
• W2074335074 startingPage "497" @default.
• W2074335074 abstract "Abstract CD19 is an attractive therapeutic target for treating human B‐cell tumors. In our study, chimeric (c) divalent (cHD37) and tetravalent (cHD37‐DcVV) anti‐CD19 monoclonal antibodies (MAbs) were constructed, expressed and evaluated for their binding to human 19‐positive (CD19 + ) tumor cell lines. They were also tested for proapoptotic activity and the ability to mediate effector functions. The antitumor activity of these MAbs was further tested in mice xenografted with the CD19 + Burkitt's lymphoma cell line, Daudi or the pre‐B acute lymphoblastic leukemia (ALL) cell line, NALM‐6. The cHD37 and cHD37‐DcVV MAbs exhibited specific binding and comparable proapoptotic activity on CD19 + tumor cell lines in vitro . In addition, the cHD37 and cHD37‐DcVV MAbs were similar in their ability to mediate antibody‐dependent cell‐mediated phagocytosis (ADCP). However, the tetravalent cHD37‐DcVV MAb bound more avidly, had a slower dissociation rate, and did not internalize as well. It also had enhanced antibody‐dependent cellular cytotoxicity (ADCC) with human but not murine effector cells. The cHD37 and cHD37‐DcVV MAbs exhibited comparable affinity for the human neonatal Fc receptor (FcRn) and similar pharmacokinetics (PKs) in mice. Moreover, all the HD37 constructs were similar in extending the survival of mice xenografted with Daudi or NALM‐6 tumor cells. Therefore, the cHD37 and cHD37‐DcVV MAbs have potent antitumor activity and should be further developed for use in humans. Although not evident in mice, due to its increased ability to mediate ADCC with human but not mouse effector cells, the cHD37‐DcVV MAb should have superior therapeutic efficacy in humans." @default.
• W2074335074 created "2016-06-24" @default.
• W2074335074 creator A5009781833 @default.
• W2074335074 creator A5018031810 @default.
• W2074335074 creator A5041111193 @default.
• W2074335074 creator A5048336252 @default.
• W2074335074 creator A5084475433 @default.
• W2074335074 date "2010-11-16" @default.
• W2074335074 modified "2023-10-18" @default.
• W2074335074 title "Chimeric, divalent and tetravalent anti-CD19 monoclonal antibodies with potent in vitro and in vivo antitumor activity against human B-cell lymphoma and pre-B acute lymphoblastic leukemia cell lines" @default.
• W2074335074 cites W1480844331 @default.
• W2074335074 cites W1487500734 @default.
• W2074335074 cites W1533824341 @default.
• W2074335074 cites W1564132479 @default.
• W2074335074 cites W1573414954 @default.
• W2074335074 cites W1607777232 @default.
• W2074335074 cites W1963635544 @default.
• W2074335074 cites W1965205681 @default.
• W2074335074 cites W1972018125 @default.
• W2074335074 cites W1979842763 @default.
• W2074335074 cites W1982022868 @default.
• W2074335074 cites W1991644988 @default.
• W2074335074 cites W1993639035 @default.
• W2074335074 cites W1997523587 @default.
• W2074335074 cites W2002161324 @default.
• W2074335074 cites W2014276741 @default.
• W2074335074 cites W2025234369 @default.
• W2074335074 cites W2026228300 @default.
• W2074335074 cites W2041142448 @default.
• W2074335074 cites W2042988739 @default.
• W2074335074 cites W2047592809 @default.
• W2074335074 cites W2048504768 @default.
• W2074335074 cites W2049439131 @default.
• W2074335074 cites W2059917238 @default.
• W2074335074 cites W2061155258 @default.
• W2074335074 cites W2066138756 @default.
• W2074335074 cites W2090770261 @default.
• W2074335074 cites W2092626768 @default.
• W2074335074 cites W2096584091 @default.
• W2074335074 cites W2104187048 @default.
• W2074335074 cites W2105569997 @default.
• W2074335074 cites W2107894877 @default.
• W2074335074 cites W2109440389 @default.
• W2074335074 cites W2136624465 @default.
• W2074335074 cites W2137593345 @default.
• W2074335074 cites W2138608284 @default.
• W2074335074 cites W2144827965 @default.
• W2074335074 cites W2163615454 @default.
• W2074335074 cites W2247915865 @default.
• W2074335074 cites W2325707043 @default.
• W2074335074 cites W2416430600 @default.
• W2074335074 cites W31270466 @default.
• W2074335074 cites W33007984 @default.
• W2074335074 cites W4238400640 @default.
• W2074335074 cites W4376542656 @default.
• W2074335074 cites W85464595 @default.
• W2074335074 doi "https://doi.org/10.1002/ijc.25695" @default.
• W2074335074 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20878959" @default.
• W2074335074 hasPublicationYear "2010" @default.
• W2074335074 type Work @default.
• W2074335074 sameAs 2074335074 @default.
• W2074335074 citedByCount "9" @default.
• W2074335074 countsByYear W20743350742012 @default.
• W2074335074 countsByYear W20743350742013 @default.
• W2074335074 countsByYear W20743350742016 @default.
• W2074335074 countsByYear W20743350742018 @default.
• W2074335074 countsByYear W20743350742021 @default.
• W2074335074 countsByYear W20743350742023 @default.
• W2074335074 crossrefType "journal-article" @default.
• W2074335074 hasAuthorship W2074335074A5009781833 @default.
• W2074335074 hasAuthorship W2074335074A5018031810 @default.
• W2074335074 hasAuthorship W2074335074A5041111193 @default.
• W2074335074 hasAuthorship W2074335074A5048336252 @default.
• W2074335074 hasAuthorship W2074335074A5084475433 @default.
• W2074335074 hasBestOaLocation W20743350741 @default.
• W2074335074 hasConcept C109316439 @default.
• W2074335074 hasConcept C150903083 @default.
• W2074335074 hasConcept C153911025 @default.
• W2074335074 hasConcept C159654299 @default.
• W2074335074 hasConcept C185592680 @default.
• W2074335074 hasConcept C202751555 @default.
• W2074335074 hasConcept C203014093 @default.
• W2074335074 hasConcept C207001950 @default.
• W2074335074 hasConcept C2778453870 @default.
• W2074335074 hasConcept C2778957590 @default.
• W2074335074 hasConcept C40677261 @default.
• W2074335074 hasConcept C502942594 @default.
• W2074335074 hasConcept C51785407 @default.
• W2074335074 hasConcept C542903549 @default.
• W2074335074 hasConcept C54355233 @default.
• W2074335074 hasConcept C55493867 @default.
• W2074335074 hasConcept C81885089 @default.
• W2074335074 hasConcept C86803240 @default.
• W2074335074 hasConceptScore W2074335074C109316439 @default.
• W2074335074 hasConceptScore W2074335074C150903083 @default.
• W2074335074 hasConceptScore W2074335074C153911025 @default.
• W2074335074 hasConceptScore W2074335074C159654299 @default.
• W2074335074 hasConceptScore W2074335074C185592680 @default.

• next